DelveInsight’s "Pulmonary Arterial Hypertension - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Pulmonary Arterial Hypertension epidemiology and market outlook for the 7MM.
Markets Covered • United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan
Study Period: 2016-2027
Pulmonary Arterial Hypertension Understanding and Treatment Algorithm The market report provides the overview of the Pulmonary Arterial Hypertension by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology and diagnostic methods. It also covers the detailed treatment approaches and therapy areas under research and development for 7MM.
Pulmonary Arterial Hypertension Epidemiology The report provides a comprehensive account of the total patient pool, diagnosed cases and potential patient pool eligible for the treatment. It also includes the explanation of changing trends of epidemiology after evaluating numerous studies, survey reports and views of key opinion leaders. The Report provides the 10 years forecast from 2018 to 2027 segmented by seven major markets, enabling to understand the potential of the Pulmonary Arterial Hypertension in the respective markets. The epidemiology data is presented with graphs and tables to provide a clear assessment of the landscape.
Pulmonary Arterial Hypertension Product Profiles & Analysis The drug chapter segment covers the complete analysis of marketed drugs and Phase III & late Phase II pipeline drugs. This division focuses on the recent breakthroughs like clinical development analysis, agreements and collaborations, clinical trial details, allotted designations, published results, pharmacological effects, patent expiry, and expected launch timings. Moreover, advantages and disadvantages of the therapy along with opinion of experts for marketed and emerging drugs are also provided.
Pulmonary Arterial Hypertension Market Outlook The report’s market outlook delivers an understanding of the country-specific revenue and share by analyzing the performance of the current therapies and potential uptake of new products. The in-depth analysis helps to recognize the growing demand of the market by evaluating the annual cost of therapy, compliance rate, competition with other therapies, covered patient segment, impact of emerging technology in the forecast period. The views from the key opinion leaders adds more value to the analysis. This segment provides the relevant graphs and tables to have an effective outline of the Pulmonary Arterial Hypertension market.
Pulmonary Arterial Hypertension Market Share by Therapies This division provides an understanding of the rate of drug uptake, drugs including both recently launched and those which show potential to get launched during the forecast period from 2016-2027. The analysis is based on patient uptake by therapies, sales projection of each drug by studying the reasons behind the maximal use of new drugs. A comparative analysis is also done on the basis of market share and size by assessing the drugs uptake to project the drug positioning in the market.
Pulmonary Arterial Hypertension Report Insights • Patient Population in Pulmonary Arterial Hypertension • Therapeutic Approaches in Pulmonary Arterial Hypertension • Pulmonary Arterial Hypertension Pipeline Analysis • Pulmonary Arterial Hypertension Market Size and Trends • Pulmonary Arterial Hypertension Market Opportunities • Impact of upcoming Therapies in Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension Report Assessment • Current Treatment Practices in Pulmonary Arterial Hypertension • Unmet Needs in Pulmonary Arterial Hypertension • Market Attractiveness • Market Drivers and Barriers
Key Benefits • The report will help to develop Business Strategies by understanding the trends shaping and driving the Pulmonary Arterial Hypertension market • Organize sales and marketing efforts by identifying the best opportunities for Pulmonary Arterial Hypertension market • To understand the future market competition in the Pulmonary Arterial Hypertension market.
Our reports have been used by over 10K customers, including:
Blood Pressure Disorders Drug Development Pipeline Review, 2018 Summary Hypertension, also referred to as high blood pressure, is a condition in which the arteries have persistently elevated blood pressure. Many factors can affect blood pressure, including hormone levels, water and salt levels in...
Blood Pressure Monitors - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Blood Pressure Monitors - Medical Devices Pipeline Assessment, 2018" provides an overview of Blood Pressure Monitors currently in pipeline stage. The report provides comprehensive...
Radiofrequency Catheters - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Radiofrequency Catheters - Medical Devices Pipeline Assessment, 2018" provides an overview of Radiofrequency Catheters currently in pipeline stage. The report provides...
Renal Denervation Catheters - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Renal Denervation Catheters - Medical Devices Pipeline Assessment, 2018" provides an overview of Renal Denervation Catheters currently in pipeline stage. The report...
129 pages •
By Infiniti Research Limited
• May 2018
About Blood Pressure Monitoring Devices BP monitoring devices are used to measure the amount of blood pumped by the heart in relation to the size and condition of the artery at differenttimes. Technavio’s analysts forecast the global blood pressure monitoring devices market to grow at a CAGR of 7.27% during the...
53 active drugs and 60+ companies analyzed Pulmonary Arterial Hypertension (PAH) is a rare and catastrophic condition, with an estimated market value of over $4 billion. The chronic and rapidly progressing disease affects around 0.2 million to 0.3 million people globally. It is characterized by enlargement of...